Sei Investments Co. Acquires 15,241 Shares of Phreesia, Inc. (NYSE:PHR)

Sei Investments Co. increased its position in Phreesia, Inc. (NYSE:PHR - Free Report) by 8.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 196,815 shares of the company's stock after purchasing an additional 15,241 shares during the period. Sei Investments Co. owned 0.34% of Phreesia worth $4,952,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. American Century Companies Inc. bought a new position in shares of Phreesia in the 4th quarter worth about $644,000. Nicholas Company Inc. purchased a new stake in Phreesia in the fourth quarter worth about $2,452,000. Swiss National Bank increased its stake in shares of Phreesia by 1.3% during the fourth quarter. Swiss National Bank now owns 107,900 shares of the company's stock valued at $2,715,000 after purchasing an additional 1,400 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Phreesia during the fourth quarter valued at approximately $932,000. Finally, PNC Financial Services Group Inc. lifted its holdings in shares of Phreesia by 9.8% during the fourth quarter. PNC Financial Services Group Inc. now owns 22,445 shares of the company's stock valued at $565,000 after purchasing an additional 2,008 shares during the last quarter. Institutional investors own 92.10% of the company's stock.

Insiders Place Their Bets

In other news, CFO Balaji Gandhi sold 1,827 shares of the firm's stock in a transaction on Wednesday, March 26th. The stock was sold at an average price of $27.46, for a total value of $50,169.42. Following the transaction, the chief financial officer now directly owns 103,591 shares in the company, valued at $2,844,608.86. This trade represents a 1.73 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, COO Evan Roberts sold 3,519 shares of the company's stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $30.06, for a total value of $105,781.14. Following the sale, the chief operating officer now owns 741,197 shares of the company's stock, valued at approximately $22,280,381.82. This trade represents a 0.47 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 164,269 shares of company stock valued at $4,661,469. Company insiders own 5.80% of the company's stock.

Remove Ads

Phreesia Stock Performance

Shares of PHR traded down $0.57 during mid-day trading on Friday, hitting $24.27. 774,052 shares of the company traded hands, compared to its average volume of 466,412. The stock has a market cap of $1.43 billion, a price-to-earnings ratio of -16.51 and a beta of 0.82. The stock has a 50-day moving average price of $27.24 and a two-hundred day moving average price of $24.22. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $30.53. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on PHR shares. Robert W. Baird reduced their price objective on Phreesia from $34.00 to $30.00 and set an "outperform" rating for the company in a research report on Wednesday, December 11th. Truist Financial lifted their price target on Phreesia from $31.00 to $34.00 and gave the stock a "buy" rating in a research report on Wednesday, December 11th. JMP Securities reissued a "market outperform" rating and set a $30.00 price objective on shares of Phreesia in a research report on Tuesday, December 10th. KeyCorp raised their price objective on shares of Phreesia from $28.00 to $30.00 and gave the company an "overweight" rating in a research note on Wednesday, January 8th. Finally, Citigroup upped their target price on shares of Phreesia from $31.00 to $35.00 and gave the stock a "buy" rating in a research note on Friday, January 10th. Twelve equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, Phreesia presently has an average rating of "Buy" and a consensus target price of $31.33.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.